Società Centrexion Therapeutics Corporation
Azioni
CNTX
US15643W1009
Biotecnologia
Attività
Numero di dipendenti: 24
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Founder | 76 | 01/02/13 | |
Jeffrey Kindler
FOU | Founder | 68 | 01/02/13 |
Chief Tech/Sci/R&D Officer | - | 01/04/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 26/06/18 |
Sol Barer
FOU | Founder | 76 | 01/02/13 |
Jeffrey Kindler
FOU | Founder | 68 | 01/02/13 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 01/02/13 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 15/08/18 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01/01/19 |
Founder | 76 | 01/02/13 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 01/01/18 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 26/06/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 669 866 | 0 | 0 | - |
Coordinate società
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |